Arthur Löve

2.8k total citations
67 papers, 1.1k citations indexed

About

Arthur Löve is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Arthur Löve has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 26 papers in Hepatology and 12 papers in Infectious Diseases. Recurrent topics in Arthur Löve's work include Hepatitis C virus research (19 papers), Virology and Viral Diseases (16 papers) and Hepatitis B Virus Studies (12 papers). Arthur Löve is often cited by papers focused on Hepatitis C virus research (19 papers), Virology and Viral Diseases (16 papers) and Hepatitis B Virus Studies (12 papers). Arthur Löve collaborates with scholars based in Iceland, Sweden and United States. Arthur Löve's co-authors include Erling Norrby, Krister Kristensson, Claes Örvell, Magnús Gottfreðsson, Tomas Olsson, Einar S. Björnsson, Robert Schwarcz, Brør Morein, Tamas M. Varsanyi and Tommy Andersson and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Arthur Löve

66 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arthur Löve Iceland 20 633 219 195 146 131 67 1.1k
Yuko Katayama Japan 18 492 0.8× 222 1.0× 187 1.0× 166 1.1× 115 0.9× 45 829
Nicola F. Fletcher Ireland 17 380 0.6× 266 1.2× 357 1.8× 103 0.7× 183 1.4× 37 1.1k
Roberto Biselli Italy 21 475 0.8× 254 1.2× 113 0.6× 344 2.4× 293 2.2× 67 1.5k
Yasuyo Kashiwagi Japan 19 461 0.7× 389 1.8× 37 0.2× 171 1.2× 147 1.1× 101 1.2k
Jorge Quarleri Argentina 19 611 1.0× 331 1.5× 446 2.3× 111 0.8× 262 2.0× 92 1.2k
M J Tarlow United Kingdom 21 490 0.8× 164 0.7× 178 0.9× 144 1.0× 146 1.1× 66 1.4k
Antonio Volpi Italy 23 979 1.5× 165 0.8× 51 0.3× 137 0.9× 162 1.2× 79 1.6k
Andréa Alice Silva Brazil 26 972 1.5× 132 0.6× 78 0.4× 217 1.5× 217 1.7× 94 1.6k
Abolghasem Ajami Iran 17 322 0.5× 129 0.6× 110 0.6× 208 1.4× 138 1.1× 74 963
Andreas Walker Germany 18 333 0.5× 603 2.8× 314 1.6× 152 1.0× 238 1.8× 46 1.1k

Countries citing papers authored by Arthur Löve

Since Specialization
Citations

This map shows the geographic impact of Arthur Löve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Löve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Löve more than expected).

Fields of papers citing papers by Arthur Löve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur Löve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Löve. The network helps show where Arthur Löve may publish in the future.

Co-authorship network of co-authors of Arthur Löve

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur Löve. A scholar is included among the top collaborators of Arthur Löve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur Löve. Arthur Löve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Löve, Arthur, et al.. (2023). 710 Real-world impact of elexacaftor-tezacaftor-ivacaftor on quality of life of adults with cystic fibrosis. Journal of Cystic Fibrosis. 22. S392–S392.
2.
Ólafsson, Sigurður, Þorvarður Jón Löve, Þórarinn Tyrfingsson, et al.. (2021). Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study. ˜The œLancet. Gastroenterology & hepatology. 6(8). 628–637. 18 indexed citations
3.
Haraldsson, Ásgeir, et al.. (2021). Burden of rotavirus disease in young children in Iceland – Time to vaccinate?. Vaccine. 39(38). 5422–5427. 1 indexed citations
4.
Smura, Teemu, Soile Blomqvist, Pekka Kolehmainen, et al.. (2020). Aseptic meningitis outbreak associated with echovirus 4 in Northern Europe in 2013–2014. Journal of Clinical Virology. 129. 104535–104535. 4 indexed citations
5.
Sallam, Malik, Joakim Esbjörnsson, Anders Widell, et al.. (2017). Molecular epidemiology of HIV-1 in Iceland: Early introductions, transmission dynamics and recent outbreaks among injection drug users. Infection Genetics and Evolution. 49. 157–163. 18 indexed citations
6.
Ólafsson, Sigurður, Þórarinn Tyrfingsson, Valgerður Rúnarsdóttir, et al.. (2017). Treatment as prevention for hepatitis C in Iceland (TRAP HEP C). A real-world experience from a nationwide elimination program using direct acting antiviral agents. Journal of Hepatology. 66(1). S72–S72. 2 indexed citations
7.
Chen, Emerson Y., Karl Baum, William Collins, et al.. (2012). Hepatitis E masquerading as drug-induced liver injury. Hepatology. 56(6). 2420–2423. 23 indexed citations
8.
Luostarinen, Tapio, Egil Jellum, Joakim Dillner, et al.. (2008). Is Smoking an Independent Risk Factor for Invasive Cervical Cancer? A Nested Case-Control Study Within Nordic Biobanks. American Journal of Epidemiology. 169(4). 480–488. 79 indexed citations
9.
Sällberg, Matti, et al.. (2005). Changing prevalence of hepatitis B virus genotypes in Iceland. Journal of Medical Virology. 77(4). 481–485. 7 indexed citations
10.
Löve, Arthur. (2000). Carotid endarterectomy and local anaesthesia: reducing the disasters. Cardiovascular Surgery. 8(6). 429–435. 30 indexed citations
11.
Löve, Arthur, Margaret Chen, & Matti Sällberg. (2000). Changing Profile of HIV-1 Serotypes in Iceland During 1989-96. Scandinavian Journal of Infectious Diseases. 32(4). 445–446. 6 indexed citations
12.
Löve, Arthur, et al.. (1999). Hepatitis G virus infections in Iceland. Journal of Viral Hepatitis. 6(3). 255–260. 10 indexed citations
13.
Guðmundsson, Grétar, Víctor Abraira, Guðmundur Guðmundsson, et al.. (1996). Whooping Cough and Parkinson's Disease. International Journal of Epidemiology. 25(6). 1301–1311. 12 indexed citations
14.
Löve, Arthur, et al.. (1995). An epidemic of hepatitis B virus infection among intravenous drug users in Iceland. European Journal of Epidemiology. 11(4). 397–402. 3 indexed citations
15.
Löve, Arthur, et al.. (1994). Hepatitis C virus infection in Iceland: a recently introduced bloodborne disease. Epidemiology and Infection. 113(3). 529–536. 9 indexed citations
16.
Eastman, Clifford L., Ewa M. Urbańska, Arthur Löve, Krister Kristensson, & Robert Schwarcz. (1994). Increased Brain Quinolinic Acid Production in Mice Infected with a Hamster Neurotropic Measles Virus. Experimental Neurology. 125(1). 119–124. 22 indexed citations
17.
Andersson, Tommy, Robert Schwarcz, Arthur Löve, & Krister Kristensson. (1993). Measles virus-induced hippocampal neurodegeneration in the mouse: A novel, subacute model for testing neuroprotective agents. Neuroscience Letters. 154(1-2). 109–112. 26 indexed citations
18.
Link, Hans, Jia‐Bin Sun, Zhenyu Wang, et al.. (1992). Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis. Journal of Neuroimmunology. 38(1-2). 63–73. 63 indexed citations
19.
Mæhlen, Jan, et al.. (1991). Paramyxovirus infections alter certain functional properties in cultured sensory neurons. Brain Research. 540(1-2). 123–130. 8 indexed citations
20.
Andersson, Tommy, et al.. (1991). NMDA‐Receptor Antagonist Prevents Measles Virus‐induced Neurodegeneration. European Journal of Neuroscience. 3(1). 66–71. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuko Katayama Breakdown of academic impact, for papers by Nicola F. Fletcher Breakdown of academic impact, for papers by Roberto Biselli Breakdown of academic impact, for papers by Yasuyo Kashiwagi Breakdown of academic impact, for papers by Jorge Quarleri Breakdown of academic impact, for papers by M J Tarlow Breakdown of academic impact, for papers by Antonio Volpi Breakdown of academic impact, for papers by Andréa Alice Silva Breakdown of academic impact, for papers by Abolghasem Ajami Breakdown of academic impact, for papers by Andreas Walker
Rankless by CCL
2026